Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis

BACKGROUND One of the earliest diagnostic signs of hepatorenal syndrome in patients suffering from liver cirrhosis is an increase in the renal vascular resistive index (RI). In this study, the impact of propranolol on decreasing this index and to postpone the probability of hepatorenal syndrome has...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezayat, Kambiz Akhavan, Zeraati, Abbas Ali, Pezeshki Rad, Masoud, Chogan, Jalal, Davoudian, Najmeh, Akhavan Rezayat, Amir, Hoseini, Seyed Mousalreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726333/
https://www.ncbi.nlm.nih.gov/pubmed/29255578
http://dx.doi.org/10.15171/mejdd.2017.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726333/
https://www.ncbi.nlm.nih.gov/pubmed/29255578
http://dx.doi.org/10.15171/mejdd.2017.75

Ejemplares similares